{"id":8099,"date":"2026-06-30T10:49:52","date_gmt":"2026-06-30T02:49:52","guid":{"rendered":"https:\/\/witology.com.tw\/daily-biohealth\/2026-06-30\/"},"modified":"2026-06-30T10:49:52","modified_gmt":"2026-06-30T02:49:52","slug":"9-84","status":"publish","type":"page","link":"https:\/\/witology.com.tw\/en\/daily-biohealth\/9-84\/","title":{"rendered":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-06-30\uff5cIpsen \u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc Kartos\uff0c\u5e03\u5c40"},"content":{"rendered":"\n<style>.wit-daily {\n  --bg:#0f0e0c;--bg2:#16140f;--fg:#e8e3d8;--dim:#8a8276;--mute:#5a5448;\n  --card:#1a1816;--card2:#221f1b;--bdr:#3a342e;--bdr2:#4a423a;\n  --acc:#c4b09a;--acc2:#d4a574;--acc3:#7a6e62;\n  --tw:#e07a6a;--us:#7ab3d4;\n  --up:#8fc78a;--dn:#d97070;--nu:#9a9282;\n  --warn:#d4a574;\n  --line-h:1.85;\n}\n.wit-daily * {margin:0;padding:0;box-sizing:border-box}\n.wit-daily {background:var(--bg)}\n.wit-daily {font-family:\"Noto Sans TC\",sans-serif;background:var(--bg);color:var(--fg);line-height:var(--line-h);-webkit-font-smoothing:antialiased;background-image:radial-gradient(ellipse 80% 40% at 50% 0%,rgba(196,176,154,.06),transparent 70%)}\n.wit-daily .wrap {max-width:860px;margin:0 auto;padding:40px 22px 80px}\n.wit-daily .hdr {text-align:center;padding:64px 0 48px;margin-bottom:48px;border-bottom:1px solid var(--bdr)}\n.wit-daily .hdr-date {font-size:12px;letter-spacing:8px;color:var(--acc);text-transform:uppercase;margin-bottom:14px;font-weight:500}\n.wit-daily .hdr h1 {font-family:\"Noto Serif TC\",serif;font-size:clamp(30px,5vw,46px);font-weight:700;letter-spacing:3px;margin-bottom:12px;background:linear-gradient(135deg,var(--fg) 0%,var(--acc) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text}\n.wit-daily .hdr-sub {font-size:13px;color:var(--dim);letter-spacing:1px}\n.wit-daily .stats {margin-bottom:48px}\n.wit-daily .st {display:flex;align-items:center;gap:12px;margin-bottom:8px}\n.wit-daily .st-bar {height:3px;border-radius:2px;min-width:3px;transition:width .5s;opacity:.85}\n.wit-daily .st-lb {font-size:13px;flex:1;color:var(--fg)}\n.wit-daily .st-ct {font-size:12px;color:var(--dim);min-width:24px;text-align:right;font-variant-numeric:tabular-nums}\n.wit-daily .lbl {font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;color:var(--fg);margin-bottom:28px;padding-bottom:12px;border-bottom:2px solid var(--acc);letter-spacing:1px}\n.wit-daily .c {background:var(--card);border:1px solid var(--bdr);border-radius:4px;margin-bottom:36px;overflow:hidden;box-shadow:0 4px 24px rgba(0,0,0,.35),0 1px 0 rgba(196,176,154,.05) inset;backdrop-filter:blur(16px)}\n.wit-daily .c-hd {display:flex;justify-content:space-between;align-items:center;padding:22px 30px 0}\n.wit-daily .c-cat {font-size:10px;font-weight:700;letter-spacing:3px;text-transform:uppercase;color:var(--cc,var(--acc));border:1px solid var(--cc,var(--acc));padding:3px 12px;border-radius:2px;background:rgba(0,0,0,.2)}\n.wit-daily .c-snt {font-size:13px;font-weight:600;letter-spacing:.5px}\n.wit-daily .s-up {color:var(--up)}\n.wit-daily .s-dn {color:var(--dn)}\n.wit-daily .s-nu {color:var(--nu)}\n.wit-daily .c-t {padding:14px 30px 4px;font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;line-height:1.45;letter-spacing:.5px}\n.wit-daily .c-t a {color:var(--fg);text-decoration:none;transition:color .25s}\n.wit-daily .c-t a:hover {color:var(--acc2)}\n.wit-daily .c-src {padding:0 30px 14px;font-size:12px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .c-hype {display:flex;align-items:center;gap:14px;padding:10px 30px 14px;border-top:1px dashed var(--bdr);border-bottom:1px dashed var(--bdr);background:rgba(196,176,154,.03)}\n.wit-daily .c-hype-lb {font-size:10px;letter-spacing:2px;text-transform:uppercase;color:var(--dim);font-weight:700}\n.wit-daily .c-hype-dots {font-size:14px;color:var(--acc2);letter-spacing:3px;font-family:monospace}\n.wit-daily .c-hype-tx {font-size:12px;color:var(--acc);font-weight:500}\n.wit-daily .c-stocks {padding:14px 30px 18px;display:flex;flex-wrap:wrap;gap:6px}\n.wit-daily .stk {display:inline-flex;align-items:center;gap:4px;font-size:12px;padding:4px 12px;border-radius:2px;font-weight:500}\n.wit-daily .stk b {font-weight:700}\n.wit-daily .stk-tw {background:rgba(224,122,106,.12);color:var(--tw);border:1px solid rgba(224,122,106,.35)}\n.wit-daily .stk-us {background:rgba(122,179,212,.12);color:var(--us);border:1px solid rgba(122,179,212,.35)}\n.wit-daily .stk-other {background:rgba(255,255,255,.04);color:var(--dim);border:1px solid var(--bdr2)}\n.wit-daily .chg {font-size:11px;font-weight:600;padding:1px 6px;border-radius:2px;margin-left:2px}\n.wit-daily .chg-up {background:rgba(226,100,80,.20);color:#ff8f78}\n.wit-daily .chg-down {background:rgba(94,181,141,.20);color:#7ed0a6}\n.wit-daily .chg-flat {background:rgba(255,255,255,.06);color:var(--dim)}\n.wit-daily .c-img {width:100%;height:auto;aspect-ratio:1170\/540;object-fit:cover;border-top:1px solid var(--bdr);border-bottom:1px solid var(--bdr);filter:brightness(.92);display:block}\n.wit-daily .c-analysis {display:grid;grid-template-columns:1fr 1fr;border-top:1px solid var(--bdr)}\n.wit-daily .c-sec {padding:22px 30px;border-bottom:1px solid var(--bdr)}\n.wit-daily .c-sec:nth-child(odd) {border-right:1px solid var(--bdr)}\n.wit-daily .c-wide {grid-column:1\/-1;border-right:none !important}\n.wit-daily .c-sec h4 {font-size:14px;letter-spacing:2px;text-transform:uppercase;color:var(--acc);margin-bottom:12px;font-weight:700}\n.wit-daily .c-sec p {font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92}\n.wit-daily .c-counter {background:rgba(212,165,116,.05)}\n.wit-daily .c-counter h4 {color:var(--warn)}\n.wit-daily .c-counter blockquote {border-left:3px solid var(--warn);padding:6px 0 6px 16px;font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92;font-style:italic;margin:0}\n.wit-daily .c-watch {background:rgba(196,176,154,.04)}\n.wit-daily .c-watch-grid {display:grid;grid-template-columns:1fr 1fr 1fr;gap:18px;margin-top:6px}\n.wit-daily .c-watch-col {}\n.wit-daily .c-watch-h {font-size:12px;font-weight:700;color:var(--fg);margin-bottom:10px;padding-bottom:6px;border-bottom:1px solid var(--bdr2);display:flex;flex-direction:column;gap:2px}\n.wit-daily .c-watch-h span {font-size:10px;color:var(--dim);letter-spacing:1px;font-weight:400}\n.wit-daily .c-w-short {border-bottom-color:var(--dn)}\n.wit-daily .c-w-mid {border-bottom-color:var(--acc2)}\n.wit-daily .c-w-long {border-bottom-color:var(--up)}\n.wit-daily .c-watch-col ul {list-style:none;padding:0;margin:0}\n.wit-daily .c-watch-col li {font-size:13px;line-height:1.7;color:var(--fg);opacity:.88;padding:6px 0 6px 16px;position:relative}\n.wit-daily .c-watch-col li:before {content:\"\u25b8\";position:absolute;left:0;color:var(--acc);font-size:12px}\n.wit-daily .c-faqs {background:rgba(122,179,212,.04)}\n.wit-daily .c-faqs h4 {color:var(--us)}\n.wit-daily .c-faq-item {border-bottom:1px solid var(--bdr);padding:10px 0}\n.wit-daily .c-faq-item:last-child {border-bottom:none}\n.wit-daily .c-faq-item summary {cursor:pointer;font-size:14px;font-weight:600;color:var(--fg);padding:6px 0;list-style:none;display:flex;align-items:center;gap:10px;transition:color .2s}\n.wit-daily .c-faq-item summary::before {content:\"+\";color:var(--us);font-weight:700;font-size:18px;width:14px;display:inline-block;transition:transform .2s}\n.wit-daily .c-faq-item[open] summary::before {content:\"\u2212\"}\n.wit-daily .c-faq-item summary:hover {color:var(--acc2)}\n.wit-daily .c-faq-item p {font-size:13px;line-height:1.8;color:var(--fg);opacity:.85;padding:8px 0 6px 24px;margin:0}\n.wit-daily .c-ft {padding:16px 30px;border-top:1px solid var(--bdr);text-align:right;background:rgba(0,0,0,.15)}\n.wit-daily .c-ft a {font-size:13px;color:var(--acc);text-decoration:none;font-weight:500;transition:color .25s;letter-spacing:.5px}\n.wit-daily .c-ft a:hover {color:var(--acc2)}\n.wit-daily .briefs {background:var(--card);border:1px solid var(--bdr);border-radius:4px;padding:8px 0;margin-bottom:48px;box-shadow:0 2px 12px rgba(0,0,0,.25)}\n.wit-daily .b-item {display:flex;gap:12px;padding:12px 26px;border-bottom:1px solid var(--bdr);align-items:flex-start}\n.wit-daily .b-item:last-child {border-bottom:none}\n.wit-daily .b-dot {width:7px;height:7px;border-radius:50%;margin-top:9px;flex-shrink:0;box-shadow:0 0 8px currentColor}\n.wit-daily .b-link {color:var(--fg);text-decoration:none;font-size:14px;transition:color .25s;display:block;margin-bottom:2px;line-height:1.6}\n.wit-daily .b-link:hover {color:var(--acc2)}\n.wit-daily .b-meta {font-size:11px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .ftr {text-align:center;padding:36px 0;font-size:11px;color:var(--mute);border-top:1px solid var(--bdr);margin-top:24px;letter-spacing:1px}\n@media(max-width:680px) {.wit-daily .c-analysis {grid-template-columns:1fr}\n.wit-daily .c-sec:nth-child(odd) {border-right:none}\n.wit-daily .c-wide {grid-column:1}\n.wit-daily .c-t {font-size:19px;padding:12px 20px 4px}\n.wit-daily .c-hd, .wit-daily .c-src, .wit-daily .c-stocks, .wit-daily .c-sec, .wit-daily .c-ft, .wit-daily .c-hype {padding-left:20px;padding-right:20px}\n.wit-daily .c-watch-grid {grid-template-columns:1fr;gap:14px}}\n\/* \u5168\u57df(\u975e scoped):\u50c5\u8a72\u7522\u696d\u65e5\u5831\u5b50\u9801\u751f\u6548 *\/\nbody.parent-pageid-7356 .fusion-page-title-bar,\nbody.parent-pageid-7356 .fusion-page-title-row,\nbody.parent-pageid-7356 .fusion-page-title-wrapper {\n  display: none !important;\n  height: 0 !important;\n  padding: 0 !important;\n  margin: 0 !important;\n}\nbody.parent-pageid-7356 #main,\nbody.parent-pageid-7356 #content,\nbody.parent-pageid-7356 .fusion-row,\nbody.parent-pageid-7356 .post-content,\nbody.parent-pageid-7356 article.post {\n  padding-top: 0 !important;\n  margin-top: 0 !important;\n}\n\n\/* scoped(.wit-daily) *\/\n.wit-daily {\n  margin-left: calc((100% - 100vw) \/ 2);\n  margin-right: calc((100% - 100vw) \/ 2);\n  padding-left: calc((100vw - 100%) \/ 2);\n  padding-right: calc((100vw - 100%) \/ 2);\n  padding-top: 40px;\n  padding-bottom: 60px;\n  background: #0f0e0c;\n  color: #e8e3d8;\n  font-family: \"Noto Sans TC\", sans-serif;\n}\n.wit-daily .wrap { padding-left: 22px; padding-right: 22px; padding-top: 0; }\n.wit-daily a { color: inherit; }\n\/* \u5f37\u5236\u8986\u84cb Avada \u4e3b\u984c\u53ef\u80fd\u6ce8\u5165\u7684 blockquote \u767d\u5e95 *\/\n.wit-daily .c-counter blockquote,\n.wit-daily blockquote {\n  background: transparent !important;\n  background-color: transparent !important;\n  color: #e8e3d8 !important;\n  border-left: 3px solid #d4a574 !important;\n  padding: 6px 0 6px 16px !important;\n  font-style: italic !important;\n  margin: 0 !important;\n  box-shadow: none !important;\n}\n.wit-daily .c-counter blockquote::before,\n.wit-daily blockquote::before,\n.wit-daily blockquote::after { content: none !important; }\n<\/style>\n<div class=\"wit-daily\">\n\n<main class=\"wrap\">\n<header class=\"hdr\">\n<div class=\"hdr-date\"><time datetime=\"2026-06-30\">2026 \u5e74 06 \u6708 30 \u65e5<\/time><\/div>\n<h1>\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831<\/h1>\n<p class=\"hdr-sub\">\u5171\u6536\u9304 5 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/p>\n<\/header>\n<section aria-labelledby=\"sec-featured\">\n<h2 class=\"lbl\" id=\"sec-featured\">\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/h2>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/ipsen-pens-17b-deal-acquire-kartos-potential-jakafi-add-therapy-myelofibrosis\" rel=\"noopener nofollow\" target=\"_blank\">Ipsen \u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc Kartos\uff0c\u5e03\u5c40\u9aa8\u9ad3\u7e96\u7dad\u5316 Jakafi \u806f\u5408\u7642\u6cd5<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-06-30\" itemprop=\"datePublished\">2026-06-30<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-other\"><b>IPN<\/b> Ipsen <span class=\"chg chg-flat\">\u2014<\/span><\/span><span class=\"stk stk-other\">Kartos Therapeutics <span class=\"chg chg-flat\">\u672a\u4e0a\u5e02<\/span><\/span><span class=\"stk stk-us\"><b>INCY<\/b> Incyte <span class=\"chg chg-up\">\u25b20.80% $114.66<\/span><\/span><span class=\"stk stk-us\"><b>NVS<\/b> Novartis <span class=\"chg chg-up\">\u25b21.40% $157.59<\/span><\/span><span class=\"stk stk-us\"><b>GSK<\/b> Sierra Oncology (GSK) <span class=\"chg chg-up\">\u25b20.59% $52.81<\/span><\/span><span class=\"stk stk-other\">CTI BioPharma (Swedish Orphan Biovitrum) <span class=\"chg chg-flat\">\u672a\u4e0a\u5e02<\/span><\/span><span class=\"stk stk-tw\"><b>6446<\/b> PharmaEssentia <span class=\"chg chg-up\">\u25b26.69% $1355.0<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u6cd5\u570b\u88fd\u85e5\u96c6\u5718 Ipsen \u5ba3\u5e03\u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc\u79c1\u4eba\u751f\u6280\u516c\u53f8 Kartos Therapeutics\uff0c\u76ee\u6a19\u9396\u5b9a Kartos \u65d7\u4e0b\u5728\u7814\u7ba1\u7dda\uff0c\u8a08\u5283\u958b\u767c\u6210\u70ba Incyte \u9aa8\u9ad3\u7e96\u7dad\u5316\uff08Myelofibrosis\uff09\u6838\u5fc3\u85e5\u7269 Jakafi\uff08ruxolitinib\uff09\u7684\u806f\u5408\u9644\u52a0\u7642\u6cd5\uff08add-on therapy\uff09\u3002\u6b64\u8209\u986f\u793a Ipsen \u7a4d\u6975\u5f9e\u50b3\u7d71\u7f55\u898b\u75be\u75c5\u8207\u816b\u7624\u9818\u57df\u5411\u8840\u6db2\u60e1\u6027\u816b\u7624\u8de8\u6b65\uff0c\u8a66\u5716\u5728\u5df2\u9ad8\u5ea6\u7af6\u722d\u7684 MF \u5e02\u5834\u4e2d\u4ee5\u300c\u806f\u5408\u7528\u85e5\u7b56\u7565\u300d\u5207\u5165\uff0c\u7e5e\u958b\u8207 Jakafi \u7684\u6b63\u9762\u7af6\u722d\u3002\u9aa8\u9ad3\u7e96\u7dad\u5316\u5e02\u5834\u8fd1\u5e74\u56e0 JAK \u6291\u5236\u5291\u52a0\u901f\u6ef2\u900f\u800c\u6210\u70ba\u8840\u6db2\u816b\u7624\u71b1\u9ede\uff0c\u591a\u5bb6\u5927\u5ee0\u6436\u9032\u7b2c\u4e8c\u7dda\u53ca\u806f\u5408\u7642\u6cd5\u7a7a\u7f3a\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u6536\u8cfc\u91d1\u984d 17 \u5104\u7f8e\u5143\uff1b\u9aa8\u9ad3\u7e96\u7dad\u5316\u5168\u7403\u5e02\u5834\u898f\u6a21\u9810\u4f30 2028 \u5e74\u9054 40\u201350 \u5104\u7f8e\u5143\uff1bJakafi\uff08ruxolitinib\uff092023 \u5e74\u5168\u7403\u92b7\u552e\u984d\u7d04 27 \u5104\u7f8e\u5143\uff0c\u70ba Incyte \u6838\u5fc3\u71df\u6536\u652f\u67f1\uff1b\u73fe\u6709 MF \u806f\u5408\u7642\u6cd5\u7af6\u54c1\u5305\u62ec Navitoclax\uff08AbbVie\uff09\u53ca Pelabresib\uff08CymaBay\/Constellation\uff09\u7b49\u591a\u500b BET \u6291\u5236\u5291\uff1bKartos \u6838\u5fc3\u8cc7\u7522\u64da\u6089\u70ba KRT-232\uff08MDM2 \u6291\u5236\u5291\uff09\uff0c\u5df2\u6709 Phase II \u6578\u64da\u65bc MF \u60a3\u8005\u4e2d\u986f\u793a\u6f5b\u529b\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Ipsen \u4ee5 17 \u5104\u7f8e\u5143\u62bc\u6ce8 Kartos\uff0c\u6a19\u8a8c\u8457\u9aa8\u9ad3\u7e96\u7dad\u5316\u5e02\u5834\u300cJakafi \u751f\u614b\u7cfb\u806f\u5408\u7642\u6cd5\u300d\u7af6\u722d\u6b63\u5f0f\u9032\u5165\u767d\u71b1\u5316\uff0c\u88fd\u85e5\u5927\u5ee0\u722d\u76f8\u6436\u4f54 JAK \u6291\u5236\u5291\u7642\u6548\u5929\u82b1\u677f\u5f8c\u7684\u4e0b\u4e00\u6ce2\u6210\u9577\u7a7a\u9593\u3002MF \u662f\u7f55\u898b\u8840\u6db2\u816b\u7624\u4e2d\u5c11\u6578\u5e02\u5834\u96c6\u4e2d\u5ea6\u9ad8\u3001\u5b9a\u50f9\u6b0a\u5f37\u7684\u9069\u61c9\u75c7\uff0cJakafi \u96d6\u70ba\u6a19\u6e96\u6cbb\u7642\uff0c\u4f46\u7d04 50% \u60a3\u8005\u5728 3\u20135 \u5e74\u5167\u51fa\u73fe\u8010\u85e5\u6216\u75be\u75c5\u9032\u5c55\uff0c\u806f\u5408\u7642\u6cd5\u7684\u81e8\u5e8a\u9700\u6c42\u7f3a\u53e3\u5de8\u5927\u3002Ipsen \u82e5\u6210\u529f\u5c07 Kartos \u7ba1\u7dda\u63a8\u9032\u81f3 Phase III \u4e26\u8207 Incyte \u5f62\u6210\u5546\u696d\u5408\u4f5c\uff0c\u5c07\u5927\u5e45\u63d0\u5347\u5176\u5728\u8840\u6db2\u816b\u7624\u7684\u5e02\u5834\u5730\u4f4d\u3002\u53f0\u7063\u65b9\u9762\uff0c\u85e5\u83ef\u85e5\uff08PharmaEssentia\uff09\u65d7\u4e0b P1101\uff08ropeginterferon\uff09\u4ea6\u5728 MF \u9069\u61c9\u75c7\u5e03\u5c40\uff0c\u9700\u5bc6\u5207\u95dc\u6ce8\u6b64\u6536\u8cfc\u5c0d MF \u7af6\u722d\u683c\u5c40\u7684\u9593\u63a5\u58d3\u529b\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>17 \u5104\u7f8e\u5143\u7684\u6536\u8cfc\u6ea2\u50f9\u662f\u5426\u5408\u7406\uff0c\u9ad8\u5ea6\u53d6\u6c7a\u65bc KRT-232 \u5c1a\u672a\u5b8c\u6210\u7684 Phase III \u6578\u64da\uff0cMDM2 \u6291\u5236\u5291\u6b77\u53f2\u4e0a\u5728\u8840\u6db2\u816b\u7624\u4e2d\u6bd2\u6027\u7ba1\u7406\u56f0\u96e3\uff0c\u82e5\u806f\u5408\u7528\u85e5\u5b89\u5168\u6027\u4e0d\u5982\u9810\u671f\u6216 Incyte \u62d2\u7d55\u5546\u696d\u5408\u4f5c\uff0cIpsen \u6050\u9762\u81e8\u8cc7\u7522\u6e1b\u503c\u98a8\u96aa\uff1b\u6b64\u5916 MF \u806f\u5408\u7642\u6cd5\u8cfd\u9053\u5df2\u6709 AbbVie Navitoclax \u7b49\u591a\u500b\u5019\u9078\u85e5\u7269\u7af6\u722d\uff0c\u5f8c\u9032\u8005\u5e02\u5834\u7a97\u53e3\u6b63\u5728\u7e2e\u7a84\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Kartos KRT-232 \u6700\u65b0\u81e8\u5e8a\u6578\u64da\u65bc ASH 2025 \u6216 EHA \u5e74\u6703\u662f\u5426\u767c\u8868<\/li><li>Ipsen \u6536\u8cfc\u4ea4\u5272\u5b8c\u6210\u6642\u9593\u9ede\u53ca\u6cd5\u898f\u5be9\u67e5\u9032\u5ea6<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>Ipsen \u555f\u52d5 KRT-232 + Jakafi Phase III \u806f\u5408\u8a66\u9a57\u7684\u8a2d\u8a08\u65b9\u6848\u8207\u6642\u7a0b<\/li><li>Incyte \u662f\u5426\u4e3b\u52d5\u5c0b\u6c42\u8207 Ipsen \u5546\u696d\u5408\u4f5c\u6216\u6388\u6b0a\u5354\u8b70<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>MDM2 \u6291\u5236\u5291\u4f5c\u70ba MF \u806f\u5408\u7642\u6cd5\u80fd\u5426\u5efa\u7acb\u5dee\u7570\u5316\u7642\u6548\u6a19\u6e96\uff0c\u5f71\u97ff\u6574\u9ad4\u8840\u6db2\u816b\u7624\u7d44\u5408\u7642\u6cd5\u683c\u5c40<\/li><li>\u53f0\u7063\u85e5\u83ef\u85e5 P1101 \u5728 MF \u9069\u61c9\u75c7\u7684\u5168\u7403\u62d3\u5c55\u662f\u5426\u53d7\u570b\u969b\u5927\u5ee0\u806f\u5408\u7642\u6cd5\u58d3\u7e2e\u5e02\u5834\u7a7a\u9593<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>Jakafi \u5df2\u662f\u9aa8\u9ad3\u7e96\u7dad\u5316\u6a19\u6e96\u6cbb\u7642\uff0c\u70ba\u4ec0\u9ebc\u9084\u9700\u8981\u806f\u5408\u7642\u6cd5\uff1f<\/summary><p>Jakafi\uff08ruxolitinib\uff09\u96d6\u80fd\u6709\u6548\u63a7\u5236\u75c7\u72c0\uff0c\u4f46\u7d04\u534a\u6578\u60a3\u8005\u5728\u6578\u5e74\u5167\u51fa\u73fe\u8010\u85e5\u6216\u75be\u75c5\u8f49\u5316\u70ba\u6025\u6027\u767d\u8840\u75c5\uff0c\u806f\u5408\u7642\u6cd5\u7684\u76ee\u7684\u662f\u5728 JAK \u6291\u5236\u4e4b\u5916\u540c\u6642\u653b\u64ca MDM2 \u7b49\u5176\u4ed6\u81f4\u75c5\u8def\u5f91\uff0c\u5ef6\u9577\u7de9\u89e3\u671f\u4e26\u63d0\u5347\u5b8c\u5168\u7de9\u89e3\u7387\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>Kartos \u7684\u6838\u5fc3\u85e5\u7269 KRT-232 \u662f\u4ec0\u9ebc\u6a5f\u5236\uff0c\u73fe\u5728\u9032\u5c55\u5230\u54ea\u500b\u968e\u6bb5\uff1f<\/summary><p>KRT-232 \u662f MDM2 \u6291\u5236\u5291\uff0c\u900f\u904e\u6062\u5fa9 p53 \u816b\u7624\u6291\u5236\u86cb\u767d\u6d3b\u6027\u4f86\u8a98\u5c0e\u764c\u7d30\u80de\u51cb\u4ea1\uff0c\u76ee\u524d\u5df2\u5b8c\u6210 Phase II \u8a66\u9a57\u4e26\u986f\u793a\u5728 MF \u60a3\u8005\u4e2d\u6709\u521d\u6b65\u7642\u6548\uff0cIpsen \u6536\u8cfc\u5f8c\u5c07\u63a8\u9032 Phase III \u806f\u5408 Jakafi \u7684\u6a1e\u7d10\u8a66\u9a57\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u9805\u6536\u8cfc\u5c0d\u53f0\u7063\u85e5\u83ef\u85e5\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f<\/summary><p>\u85e5\u83ef\u85e5\u7684 ropeginterferon\uff08P1101\uff09\u6b63\u5728\u7533\u8acb MF \u9069\u61c9\u75c7\uff0c\u82e5 Ipsen\/Kartos \u806f\u5408\u7642\u6cd5\u6210\u529f\u5efa\u7acb\u65b0\u6cbb\u7642\u6a19\u6e96\uff0c\u5c07\u58d3\u7e2e\u5e72\u64fe\u7d20\u985e\u85e5\u7269\u5728 MF \u5e02\u5834\u7684\u5b9a\u4f4d\u7a7a\u9593\uff0c\u85e5\u83ef\u85e5\u9700\u52a0\u901f\u5dee\u7570\u5316\u81e8\u5e8a\u6578\u64da\u7684\u53d6\u5f97\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/ipsen-pens-17b-deal-acquire-kartos-potential-jakafi-add-therapy-myelofibrosis\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#ED7D31\">\u91ab\u7642\u5668\u6750<\/span>\n<span class=\"c-snt s-dn\">\u25bc \u504f\u7a7a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/medtech\/production-problems-hamper-lantheus-bid-fda-approval-radiopharma-dx-kit\" rel=\"noopener nofollow\" target=\"_blank\">\u751f\u7522\u554f\u984c\u963b\u7919 Lantheus \u653e\u5c04\u6027\u85e5\u7269\u8a3a\u65b7\u5957\u7d44\u7684 FDA \u6838\u51c6\u7533\u8acb<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-06-30\" itemprop=\"datePublished\">2026-06-30<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cb\u25cb\u25cb<\/span><span class=\"c-hype-tx\">2\/5 \u00b7 \u6b21\u8981\u52d5\u614b<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>LNTH<\/b> Lantheus Holdings <span class=\"chg chg-down\">\u25bc0.20% $109.58<\/span><\/span><span class=\"stk stk-us\"><b>NVS<\/b> Novartis (Advanced Accelerator Applications) <span class=\"chg chg-up\">\u25b21.40% $157.59<\/span><\/span><span class=\"stk stk-us\"><b>LLY<\/b> Eli Lilly <span class=\"chg chg-up\">\u25b21.81% $1229.93<\/span><\/span><span class=\"stk stk-other\">Point Biopharma (Eli Lilly) <span class=\"chg chg-flat\">\u672a\u4e0a\u5e02<\/span><\/span><span class=\"stk stk-us\"><b>BMY<\/b> Bristol-Myers Squibb (RayzeBio) <span class=\"chg chg-up\">\u25b21.81% $58.56<\/span><\/span><span class=\"stk stk-us\"><b>GEHC<\/b> GE HealthCare <span class=\"chg chg-down\">\u25bc1.08% $65.05<\/span><\/span><span class=\"stk stk-other\">Curium Pharma <span class=\"chg chg-flat\">\u672a\u4e0a\u5e02<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Lantheus Holdings \u5728\u5411 FDA \u7533\u8acb\u5176\u653e\u5c04\u6027\u85e5\u7269\u8a3a\u65b7\u5957\u7d44\uff08radiopharma diagnostic kit\uff09\u6838\u51c6\u7684\u904e\u7a0b\u4e2d\uff0c\u906d\u9047\u751f\u7522\u88fd\u9020\u554f\u984c\uff0c\u5c0e\u81f4\u5be9\u67e5\u9032\u7a0b\u53d7\u963b\u3002\u653e\u5c04\u6027\u8a3a\u65b7\u85e5\u7269\u7684\u88fd\u9020\u6d41\u7a0b\u9ad8\u5ea6\u654f\u611f\uff0c\u6d89\u53ca\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u534a\u8870\u671f\u7ba1\u63a7\u3001GMP \u5408\u898f\u53ca\u8a2d\u65bd\u8a8d\u8b49\u7b49\u8907\u96dc\u8981\u6c42\uff0c\u4efb\u4f55\u751f\u7522\u7aef\u7f3a\u5931\u5747\u53ef\u80fd\u89f8\u767c FDA \u7684\u5b8c\u6574\u56de\u61c9\u51fd\uff08Complete Response Letter, CRL\uff09\u6216\u8981\u6c42\u88dc\u4ef6\u3002\u6b64\u4e8b\u4ef6\u51f8\u986f\u653e\u5c04\u6027\u85e5\u7269\u7522\u696d\u5728\u5feb\u901f\u64f4\u5f35\u671f\u9593\uff0c\u88fd\u9020\u80fd\u529b\u8207\u6cd5\u898f\u5408\u898f\u4e4b\u9593\u7684\u7d50\u69cb\u6027\u5f35\u529b\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>Lantheus 2023 \u5e74\u5168\u5e74\u71df\u6536\u7d04 13.4 \u5104\u7f8e\u5143\uff0c\u5176\u4e2d\u6838\u5fc3\u7522\u54c1 PYLARIFY\uff08piflufolastat F18\uff0c\u524d\u5217\u817a\u764c PET \u8a3a\u65b7\uff09\u8ca2\u737b\u8d85\u904e 8 \u5104\u7f8e\u5143\uff1b\u5168\u7403\u653e\u5c04\u6027\u85e5\u7269\uff08radiopharmaceuticals\uff09\u5e02\u5834\u9810\u4f30 2030 \u5e74\u9054 120\u2013150 \u5104\u7f8e\u5143\uff0c\u5e74\u8907\u5408\u6210\u9577\u7387\u903e 12%\uff1bLantheus \u80a1\u50f9\u65bc\u76f8\u95dc\u6d88\u606f\u767c\u5e03\u5f8c\u627f\u58d3\uff1bFDA \u5c0d\u653e\u5c04\u6027\u85e5\u7269 NDA\/BLA \u7684\u5be9\u67e5\u5e73\u5747\u6642\u9593\u70ba 12 \u500b\u6708\uff0c\u88fd\u9020\u7f3a\u9677\u53ef\u5ef6\u9577 6\u201312 \u500b\u6708\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Lantheus \u56e0\u88fd\u9020\u554f\u984c\u53d7\u963b\uff0c\u63ed\u793a\u653e\u5c04\u6027\u85e5\u7269\u7522\u696d\u5728\u7206\u767c\u5f0f\u6210\u9577\u4e0b\uff0c\u88fd\u9020\u7aef\u5408\u898f\u80fd\u529b\u5df2\u6210\u70ba\u6838\u51c6\u6642\u7a0b\u6700\u5927\u8b8a\u6578\uff0c\u9019\u5c0d\u6574\u500b radiopharma \u8cfd\u9053\u7684\u6295\u8cc7\u4f30\u503c\u908f\u8f2f\u662f\u91cd\u8981\u8b66\u793a\u3002\u653e\u5c04\u6027\u8a3a\u65b7\u5957\u7d44\u4e0d\u540c\u65bc\u4e00\u822c\u85e5\u7269\uff0c\u5176\u751f\u7522\u9700\u7d50\u5408\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u4f9b\u61c9\u93c8\uff08\u5982 F-18\u3001Ga-68\uff09\u3001\u77ed\u534a\u8870\u671f\u7269\u6d41\u7ba1\u7406\u8207\u8a2d\u65bd GMP \u8a8d\u8b49\u4e09\u91cd\u6311\u6230\uff0c\u4efb\u4f55\u74b0\u7bc0\u7684\u7f3a\u53e3\u90fd\u53ef\u80fd\u88ab FDA \u8996\u70ba\u91cd\u5927\u7f3a\u5931\u3002\u6b64\u4e8b\u4ef6\u4e5f\u9593\u63a5\u63d0\u5347 GE HealthCare\u3001Curium \u7b49\u6210\u719f\u6838\u91ab\u8a3a\u65b7\u5ee0\u5546\u7684\u7af6\u722d\u58c1\u58d8\uff0c\u56e0\u5176\u88fd\u9020\u57fa\u790e\u8a2d\u65bd\u66f4\u70ba\u5b8c\u5099\u3002\u53f0\u7063\u5728\u653e\u5c04\u6027\u85e5\u7269\u9818\u57df\u5e03\u5c40\u76f8\u5c0d\u6709\u9650\uff0c\u4f46\u6b64\u4e8b\u4ef6\u503c\u5f97\u95dc\u6ce8\uff0c\u56e0\u70ba\u672a\u4f86\u82e5\u6709\u53f0\u5ee0\u5207\u5165\u6838\u91ab\u8a3a\u65b7 CDMO\uff0c\u88fd\u9020\u5408\u898f\u80fd\u529b\u5c07\u662f\u9996\u8981\u9580\u6abb\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u88fd\u9020\u554f\u984c\u5728\u653e\u5c04\u6027\u85e5\u7269\u7522\u696d\u4e26\u975e\u7f55\u898b\uff0cLantheus \u4f5c\u70ba\u8a72\u9818\u57df\u9f8d\u982d\u5177\u5099\u5145\u8db3\u7684\u6280\u8853\u8207\u8cc7\u6e90\u89e3\u6c7a\u554f\u984c\uff0c\u5e02\u5834\u5c0d\u6b64\u4e8b\u7684\u77ed\u671f\u8ca0\u9762\u53cd\u61c9\u53ef\u80fd\u904e\u5ea6\uff1bPYLARIFY \u65e2\u6709\u5546\u696d\u6210\u529f\u63d0\u4f9b\u5145\u88d5\u73fe\u91d1\u6d41\uff0c\u4fee\u6b63\u751f\u7522\u554f\u984c\u5f8c\u91cd\u65b0\u63d0\u4ea4\u7684\u6210\u529f\u6a5f\u7387\u4ecd\u9ad8\uff0c\u9577\u671f\u57fa\u672c\u9762\u4e26\u672a\u5be6\u8cea\u60e1\u5316\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>FDA \u662f\u5426\u767c\u51fa\u5b8c\u6574\u56de\u61c9\u51fd\uff08CRL\uff09\u53ca\u5177\u9ad4\u8981\u6c42\u88dc\u6b63\u4e8b\u9805\u7684\u516c\u544a<\/li><li>Lantheus \u7ba1\u7406\u5c64\u65bc\u4e0b\u5b63\u8ca1\u5831\u6cd5\u8aaa\u6703\u5c0d\u751f\u7522\u554f\u984c\u4fee\u6b63\u6642\u7a0b\u7684\u8aaa\u660e<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>Lantheus \u91cd\u65b0\u63d0\u4ea4 NDA \u7533\u8acb\u7684\u6642\u9593\u9ede\u53ca FDA \u53d7\u7406\u9032\u5ea6<\/li><li>\u7af6\u722d\u5c0d\u624b\u662f\u5426\u8d81\u6a5f\u52a0\u901f\u63a8\u9032\u985e\u4f3c\u653e\u5c04\u6027\u8a3a\u65b7\u5957\u7d44\u7684\u7533\u8acb\u6436\u4f54\u5148\u6a5f<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>FDA \u662f\u5426\u91dd\u5c0d\u653e\u5c04\u6027\u85e5\u7269\u88fd\u9020\u7aef\u767c\u5e03\u66f4\u56b4\u683c\u7684 GMP \u6307\u5f15\uff0c\u5f71\u97ff\u6574\u9ad4\u7522\u696d\u9032\u5165\u9580\u6abb<\/li><li>\u5168\u7403\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u4f9b\u61c9\u93c8\u96c6\u4e2d\u5316\u98a8\u96aa\u662f\u5426\u63a8\u52d5\u5ee0\u5546\u5efa\u7acb\u5728\u5730\u5316\u751f\u7522\u8a2d\u65bd<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u653e\u5c04\u6027\u85e5\u7269\u7684\u751f\u7522\u70ba\u4ec0\u9ebc\u7279\u5225\u96e3\u901a\u904e FDA \u5be9\u67e5\uff1f<\/summary><p>\u653e\u5c04\u6027\u85e5\u7269\u7d50\u5408\u4e86\u5316\u5b78\u5408\u6210\u3001\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u8655\u7406\u8207\u7121\u83cc\u88fd\u5291\u4e09\u7a2e\u9ad8\u6a19\u6e96\u8981\u6c42\uff0c\u52a0\u4e0a\u534a\u8870\u671f\u77ed\uff08F-18 \u50c5 110 \u5206\u9418\uff09\u5c0e\u81f4\u54c1\u7ba1\u7a97\u53e3\u6975\u7a84\uff0cFDA \u5c0d\u6b64\u985e\u7522\u54c1\u7684\u88fd\u9020\u8a2d\u65bd\u67e5\u5ee0\u6a19\u6e96\u6bd4\u4e00\u822c\u85e5\u5ee0\u66f4\u70ba\u56b4\u82db\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u6b21\u751f\u7522\u554f\u984c\u6703\u8b93 Lantheus \u5931\u53bb\u5e02\u5834\u5148\u6a5f\u55ce\uff1f<\/summary><p>\u77ed\u671f\u5167\u6709\u98a8\u96aa\uff0c\u82e5\u6838\u51c6\u5ef6\u9072 6\u201312 \u500b\u6708\uff0c\u7af6\u722d\u5c0d\u624b\uff08\u5982 GE HealthCare \u6216 Curium\uff09\u53ef\u80fd\u6436\u5148\u4f54\u64da\u540c\u985e\u8a3a\u65b7\u5957\u7d44\u5e02\u5834\uff1b\u4f46 Lantheus \u6191\u501f PYLARIFY \u65e2\u6709\u7684\u816b\u7624\u79d1\u901a\u8def\u512a\u52e2\uff0c\u5373\u4f7f\u6838\u51c6\u5ef6\u5f8c\u4ecd\u5177\u5546\u696d\u5316\u80fd\u529b\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u5c0d\u6295\u8cc7 Lantheus \u80a1\u7968\u7684\u4eba\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f<\/summary><p>\u77ed\u671f\u69cb\u6210\u8ca0\u9762\u50ac\u5316\u5291\uff0c\u80a1\u50f9\u53ef\u80fd\u56e0\u6838\u51c6\u6642\u7a0b\u5ef6\u5f8c\u9810\u671f\u800c\u627f\u58d3\uff1b\u4f46 Lantheus \u6838\u5fc3\u6536\u5165\u4f86\u81ea\u5df2\u4e0a\u5e02\u7684 PYLARIFY\uff0c\u57fa\u672c\u9762\u672a\u53d7\u6839\u672c\u885d\u64ca\uff0c\u4e2d\u9577\u671f\u4ecd\u9700\u89c0\u5bdf\u7ba1\u7406\u5c64\u4fee\u6b63\u88fd\u9020\u554f\u984c\u7684\u57f7\u884c\u901f\u5ea6\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/medtech\/production-problems-hamper-lantheus-bid-fda-approval-radiopharma-dx-kit\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<\/section>\n<section aria-labelledby=\"sec-briefs\">\n<h2 class=\"lbl\" id=\"sec-briefs\">\u4eca\u65e5\u5feb\u8a0a<\/h2>\n<ul class=\"briefs\" style=\"list-style:none\">\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#ED7D31\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/medtech\/united-therapeutics-nabs-fda-approval-donor-lungs-assessment-device\" rel=\"noopener nofollow\" target=\"_blank\">United Therapeutics nabs FDA approval for donor-lung assessment device<\/a>\n<span class=\"b-meta\">\u91ab\u7642\u5668\u6750 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/manufacturing\/fda-rejects-sobi-gout-drug-over-manufacturing-issues-sparing-amgen-blockbuster\" rel=\"noopener nofollow\" target=\"_blank\">FDA rejects Sobi&#8217;s gout drug over manufacturing issues, sparing Amgen blockbuster<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<\/ul>\n<\/section>\n<section aria-labelledby=\"sec-stats\" class=\"stats\" style=\"margin-top:48px\">\n<h2 class=\"lbl\" id=\"sec-stats\" style=\"font-size:16px;border-bottom-width:1px\">\u5206\u985e\u7d71\u8a08<\/h2>\n<div class=\"st\"><div class=\"st-bar\" style=\"width:60.0%;background:#4472C4\"><\/div><span class=\"st-lb\">\u85e5\u7269<\/span><span class=\"st-ct\">3<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:40.0%;background:#ED7D31\"><\/div><span class=\"st-lb\">\u91ab\u7642\u5668\u6750<\/span><span class=\"st-ct\">2<\/span><\/div>\n<\/section>\n<!-- footer \u5df2\u79fb\u9664(v2.14.0) -->\n<\/main>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2026 \u5e74 06 \u6708 30 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 \u5171\u6536\u9304 5 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790 \u7cbe\u9078 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":7356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"rank_math_title":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-06-30\uff5cIpsen \u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc Kartos\uff0c\u5e03\u5c40","rank_math_description":"2026 \u5e74 06 \u6708 30 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aIpsen \u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc Kartos\uff0c\u5e03\u5c40\u9aa8\u9ad3\u7e96\u7dad\u5316 Jak\u3001\u751f\u7522\u554f\u984c\u963b\u7919 Lantheus \u653e\u5c04\u6027\u85e5\u7269\u8a3a\u65b7\u5957\u7d44\u7684 FDA \u6838\u51c6\u7533\u8acb\u3002\u5171\u6536\u9304 5 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002","rank_math_focus_keyword":"\u751f\u91ab\u5927\u5065\u5eb7","rank_math_robots":"","daily_schema_jsonld":"[\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"CollectionPage\",\n    \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-06-30\uff5cIpsen \u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc Kartos\uff0c\u5e03\u5c40\",\n    \"description\": \"2026 \u5e74 06 \u6708 30 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aIpsen \u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc Kartos\uff0c\u5e03\u5c40\u9aa8\u9ad3\u7e96\u7dad\u5316 Jak\u3001\u751f\u7522\u554f\u984c\u963b\u7919 Lantheus \u653e\u5c04\u6027\u85e5\u7269\u8a3a\u65b7\u5957\u7d44\u7684 FDA \u6838\u51c6\u7533\u8acb\u3002\u5171\u6536\u9304 5 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002\",\n    \"url\": \"https:\/\/witology.com.tw\/daily\/2026-06-30\",\n    \"datePublished\": \"2026-06-30\",\n    \"inLanguage\": \"zh-TW\",\n    \"publisher\": {\n      \"@type\": \"Organization\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n      }\n    },\n    \"isPartOf\": {\n      \"@type\": \"WebSite\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"url\": \"https:\/\/witology.com.tw\"\n    },\n    \"hasPart\": [\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Ipsen \u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc Kartos\uff0c\u5e03\u5c40\u9aa8\u9ad3\u7e96\u7dad\u5316 Jakafi \u806f\u5408\u7642\u6cd5\",\n        \"datePublished\": \"2026-06-30\",\n        \"dateModified\": \"2026-06-30\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-06-30#article-1\"\n        },\n        \"description\": \"\u6cd5\u570b\u88fd\u85e5\u96c6\u5718 Ipsen \u5ba3\u5e03\u4ee5 17 \u5104\u7f8e\u5143\u6536\u8cfc\u79c1\u4eba\u751f\u6280\u516c\u53f8 Kartos Therapeutics\uff0c\u76ee\u6a19\u9396\u5b9a Kartos \u65d7\u4e0b\u5728\u7814\u7ba1\u7dda\uff0c\u8a08\u5283\u958b\u767c\u6210\u70ba Incyte \u9aa8\u9ad3\u7e96\u7dad\u5316\uff08Myelofibrosis\uff09\u6838\u5fc3\u85e5\u7269 Jakafi\uff08ruxolitinib\uff09\u7684\u806f\u5408\u9644\u52a0\u7642\u6cd5\uff08add-on therapy\uff09\u3002\u6b64\u8209\u986f\u793a Ipsen \u7a4d\u6975\u5f9e\u50b3\u7d71\u7f55\u898b\u75be\u75c5\u8207\u816b\u7624\u9818\u57df\u5411\u8840\u6db2\u60e1\u6027\u816b\u7624\u8de8\u6b65\uff0c\u8a66\u5716\u5728\u5df2\u9ad8\u5ea6\u7af6\u722d\u7684 MF\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-06-30#article-1\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/ipsen-pens-17b-deal-acquire-kartos-potential-jakafi-add-therapy-myelofibrosis\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Ipsen\",\n            \"tickerSymbol\": \"IPN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Kartos Therapeutics\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Incyte\",\n            \"tickerSymbol\": \"INCY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novartis\",\n            \"tickerSymbol\": \"NVS\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Sierra Oncology (GSK)\",\n            \"tickerSymbol\": \"GSK\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"CTI BioPharma (Swedish Orphan Biovitrum)\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"PharmaEssentia\",\n            \"tickerSymbol\": \"6446\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"\u751f\u7522\u554f\u984c\u963b\u7919 Lantheus \u653e\u5c04\u6027\u85e5\u7269\u8a3a\u65b7\u5957\u7d44\u7684 FDA \u6838\u51c6\u7533\u8acb\",\n        \"datePublished\": \"2026-06-30\",\n        \"dateModified\": \"2026-06-30\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-06-30#article-2\"\n        },\n        \"description\": \"Lantheus Holdings \u5728\u5411 FDA \u7533\u8acb\u5176\u653e\u5c04\u6027\u85e5\u7269\u8a3a\u65b7\u5957\u7d44\uff08radiopharma diagnostic kit\uff09\u6838\u51c6\u7684\u904e\u7a0b\u4e2d\uff0c\u906d\u9047\u751f\u7522\u88fd\u9020\u554f\u984c\uff0c\u5c0e\u81f4\u5be9\u67e5\u9032\u7a0b\u53d7\u963b\u3002\u653e\u5c04\u6027\u8a3a\u65b7\u85e5\u7269\u7684\u88fd\u9020\u6d41\u7a0b\u9ad8\u5ea6\u654f\u611f\uff0c\u6d89\u53ca\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u7684\u534a\u8870\u671f\u7ba1\u63a7\u3001GMP \u5408\u898f\u53ca\u8a2d\u65bd\u8a8d\u8b49\u7b49\u8907\u96dc\u8981\u6c42\uff0c\u4efb\u4f55\u751f\u7522\u7aef\u7f3a\u5931\u5747\u53ef\u80fd\u89f8\u767c FDA \u7684\u5b8c\u6574\u56de\u61c9\u51fd\uff08Complete Response Letter, CRL\uff09\u6216\u8981\u6c42\u88dc\u4ef6\u3002\u6b64\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-06-30#article-2\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/medtech\/production-problems-hamper-lantheus-bid-fda-approval-radiopharma-dx-kit\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Lantheus Holdings\",\n            \"tickerSymbol\": \"LNTH\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novartis (Advanced Accelerator Applications)\",\n            \"tickerSymbol\": \"NVS\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eli Lilly\",\n            \"tickerSymbol\": \"LLY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Point Biopharma (Eli Lilly)\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Bristol-Myers Squibb (RayzeBio)\",\n            \"tickerSymbol\": \"BMY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"GE HealthCare\",\n            \"tickerSymbol\": \"GEHC\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Curium Pharma\"\n          }\n        ]\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"BreadcrumbList\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 1,\n        \"name\": \"\u9996\u9801\",\n        \"item\": \"https:\/\/witology.com.tw\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 2,\n        \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 3,\n        \"name\": \"2026-06-30\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\/2026-06-30\"\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"FAQPage\",\n    \"mainEntity\": [\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Jakafi \u5df2\u662f\u9aa8\u9ad3\u7e96\u7dad\u5316\u6a19\u6e96\u6cbb\u7642\uff0c\u70ba\u4ec0\u9ebc\u9084\u9700\u8981\u806f\u5408\u7642\u6cd5\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"Jakafi\uff08ruxolitinib\uff09\u96d6\u80fd\u6709\u6548\u63a7\u5236\u75c7\u72c0\uff0c\u4f46\u7d04\u534a\u6578\u60a3\u8005\u5728\u6578\u5e74\u5167\u51fa\u73fe\u8010\u85e5\u6216\u75be\u75c5\u8f49\u5316\u70ba\u6025\u6027\u767d\u8840\u75c5\uff0c\u806f\u5408\u7642\u6cd5\u7684\u76ee\u7684\u662f\u5728 JAK \u6291\u5236\u4e4b\u5916\u540c\u6642\u653b\u64ca MDM2 \u7b49\u5176\u4ed6\u81f4\u75c5\u8def\u5f91\uff0c\u5ef6\u9577\u7de9\u89e3\u671f\u4e26\u63d0\u5347\u5b8c\u5168\u7de9\u89e3\u7387\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Kartos \u7684\u6838\u5fc3\u85e5\u7269 KRT-232 \u662f\u4ec0\u9ebc\u6a5f\u5236\uff0c\u73fe\u5728\u9032\u5c55\u5230\u54ea\u500b\u968e\u6bb5\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"KRT-232 \u662f MDM2 \u6291\u5236\u5291\uff0c\u900f\u904e\u6062\u5fa9 p53 \u816b\u7624\u6291\u5236\u86cb\u767d\u6d3b\u6027\u4f86\u8a98\u5c0e\u764c\u7d30\u80de\u51cb\u4ea1\uff0c\u76ee\u524d\u5df2\u5b8c\u6210 Phase II \u8a66\u9a57\u4e26\u986f\u793a\u5728 MF \u60a3\u8005\u4e2d\u6709\u521d\u6b65\u7642\u6548\uff0cIpsen \u6536\u8cfc\u5f8c\u5c07\u63a8\u9032 Phase III \u806f\u5408 Jakafi \u7684\u6a1e\u7d10\u8a66\u9a57\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u9805\u6536\u8cfc\u5c0d\u53f0\u7063\u85e5\u83ef\u85e5\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u85e5\u83ef\u85e5\u7684 ropeginterferon\uff08P1101\uff09\u6b63\u5728\u7533\u8acb MF \u9069\u61c9\u75c7\uff0c\u82e5 Ipsen\/Kartos \u806f\u5408\u7642\u6cd5\u6210\u529f\u5efa\u7acb\u65b0\u6cbb\u7642\u6a19\u6e96\uff0c\u5c07\u58d3\u7e2e\u5e72\u64fe\u7d20\u985e\u85e5\u7269\u5728 MF \u5e02\u5834\u7684\u5b9a\u4f4d\u7a7a\u9593\uff0c\u85e5\u83ef\u85e5\u9700\u52a0\u901f\u5dee\u7570\u5316\u81e8\u5e8a\u6578\u64da\u7684\u53d6\u5f97\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u653e\u5c04\u6027\u85e5\u7269\u7684\u751f\u7522\u70ba\u4ec0\u9ebc\u7279\u5225\u96e3\u901a\u904e FDA \u5be9\u67e5\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u653e\u5c04\u6027\u85e5\u7269\u7d50\u5408\u4e86\u5316\u5b78\u5408\u6210\u3001\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u8655\u7406\u8207\u7121\u83cc\u88fd\u5291\u4e09\u7a2e\u9ad8\u6a19\u6e96\u8981\u6c42\uff0c\u52a0\u4e0a\u534a\u8870\u671f\u77ed\uff08F-18 \u50c5 110 \u5206\u9418\uff09\u5c0e\u81f4\u54c1\u7ba1\u7a97\u53e3\u6975\u7a84\uff0cFDA \u5c0d\u6b64\u985e\u7522\u54c1\u7684\u88fd\u9020\u8a2d\u65bd\u67e5\u5ee0\u6a19\u6e96\u6bd4\u4e00\u822c\u85e5\u5ee0\u66f4\u70ba\u56b4\u82db\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u6b21\u751f\u7522\u554f\u984c\u6703\u8b93 Lantheus \u5931\u53bb\u5e02\u5834\u5148\u6a5f\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u77ed\u671f\u5167\u6709\u98a8\u96aa\uff0c\u82e5\u6838\u51c6\u5ef6\u9072 6\u201312 \u500b\u6708\uff0c\u7af6\u722d\u5c0d\u624b\uff08\u5982 GE HealthCare \u6216 Curium\uff09\u53ef\u80fd\u6436\u5148\u4f54\u64da\u540c\u985e\u8a3a\u65b7\u5957\u7d44\u5e02\u5834\uff1b\u4f46 Lantheus \u6191\u501f PYLARIFY \u65e2\u6709\u7684\u816b\u7624\u79d1\u901a\u8def\u512a\u52e2\uff0c\u5373\u4f7f\u6838\u51c6\u5ef6\u5f8c\u4ecd\u5177\u5546\u696d\u5316\u80fd\u529b\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u5c0d\u6295\u8cc7 Lantheus \u80a1\u7968\u7684\u4eba\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u77ed\u671f\u69cb\u6210\u8ca0\u9762\u50ac\u5316\u5291\uff0c\u80a1\u50f9\u53ef\u80fd\u56e0\u6838\u51c6\u6642\u7a0b\u5ef6\u5f8c\u9810\u671f\u800c\u627f\u58d3\uff1b\u4f46 Lantheus \u6838\u5fc3\u6536\u5165\u4f86\u81ea\u5df2\u4e0a\u5e02\u7684 PYLARIFY\uff0c\u57fa\u672c\u9762\u672a\u53d7\u6839\u672c\u885d\u64ca\uff0c\u4e2d\u9577\u671f\u4ecd\u9700\u89c0\u5bdf\u7ba1\u7406\u5c64\u4fee\u6b63\u88fd\u9020\u554f\u984c\u7684\u57f7\u884c\u901f\u5ea6\u3002\"\n        }\n      }\n    ]\n  }\n]","daily_standalone_url":"","footnotes":""},"class_list":["post-8099","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/comments?post=8099"}],"version-history":[{"count":0,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8099\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7356"}],"wp:attachment":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/media?parent=8099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}